Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Operating Activities:
Net loss	$ (7,580,493)	$ (12,649,291)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	289,324	1,012,185
Share based compensation	24,822	108,717
Warrant expense	0	335,739
Realized gain on sale of assets	(14,000)	(1,199,606)
Amortization of financing costs to interest expense	21,750	73,018
Non-cash interest expense	935,190	1,273,087
Amortization of debt discount	3,690,823	3,656,430
Bad debt expense	(8,868)	514
Accrued litigation settlement	0	(339,481)
Write-down of inventory	0	363,758
Write down of patents	59,153	0
Warranty reserve	(9,702)	(71,355)
Change in fair value of derivatives and (gain)/loss on extinguishment of liabilities, net	(2,599,870)	(3,753,466)
Inducement conversion costs	0	635,514
Changes in operating assets and liabilities:
Accounts receivable	(16,340)	545,481
Inventories	68,759	1,139,001
Prepaid expenses and other current assets	247,919	493,008
Accounts payable	965,175	(1,469,670)
Related party payable	(2,827)	(13,287)
Accrued expenses	885,788	(850,316)
Net cash used in operating activities	(3,043,397)	(10,710,020)
Investing Activities:
Proceeds from the sale of assets	14,000	150,000
Purchase of property, plant, and equipment	0	(6,402)
Patent activity costs	(9,705)	(50,898)
Net cash provided by investing activities	4,295	92,700
Financing Activities:
Proceeds from issuance of debt	3,102,500	4,365,000
Proceeds from issuance of stock	0	9,010,000
Payment of debt financing costs	(5,500)	(20,000)
Repayment of debt	(89,686)	(1,785,597)
Net cash provided by financing activities	3,007,314	11,569,403
Net change in cash and cash equivalents	(31,788)	952,083
Cash and cash equivalents at beginning of period	89,618	130,946
Cash and cash equivalents at end of period	57,830	1,083,029
Supplemental Cash Flow Information:
Cash paid for interest	308,542	1,120,350
Cash paid for income taxes	0	0
Non-Cash Transactions:
Non-cash conversions of convertible notes and preferred stock	5,843,954	10,914,988
Interest converted to principal	140,355	104,199
Initial derivatives	2,736,724	0
Make-whole dividend	0	257,152
Accounts payable converted to notes payable	308,041	1,637,260
Non-cash finance costs	25,000	2,500
Accounts payable forgiven in relation to Sale of EnerPlex	0	1,031,726
Promissory notes exchanged for convertible notes	511,871	0
Stock issued for commitment fee	$ 0	$ 63,750